ITMCTR2200005594尚未招募未知
Clinical study of Yigu Decoction regulating intestinal microecology in patients with osteoporotic hip fracture
The Third Affiliated Hospital of Zhejiang Chinese Medical University0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 65 至 95(—)
- 性别
- All
入选标准
- •(1) In line with the diagnostic criteria and age criteria of this subject: men are over 70 years old and women are generally more than 20 years after menopause;
- •(2) Those who did not take anti osteoporosis drugs within 3 months were included in the criteria;
- •(3) Patients willing to take traditional Chinese medicine decoction;
- •(4) Conform to normal height / body mass index, activity level (physical activity scale, PAS) = 180 points, no bad habits;
- •(5) Sign the clinical study informed consent form.
排除标准
- •(1) Non hip trochanteric fracture, such as femoral neck fracture, femoral head fracture, acetabular fracture and other diseases.
- •(2) Patients with high-energy injury and multiple fractures; Postmenopausal women whose menopause time is less than 20 years.
- •(3) It is complicated with serious chronic primary diseases such as cardio cerebrovascular, liver, kidney, respiratory system and hematopoietic system, various digestive system diseases, psychiatric patients, and the following secondary osteoporosis patients: ? endocrine cortisol increase, hyperthyroidism, primary hyperparathyroidism, acromegaly, hypogonadism Diabetes and so on. ? Nutritional protein deficiency, vitamin C deficiency, low calcium diet, alcoholism, etc. ? Hereditary osteogenesis imperfecta chromosome abnormality. ? Liver disease. ? Kidney disease chronic nephritis hemodialysis. ? Drugs: corticosteroids, antiepileptic drugs, antineoplastic drugs (such as methotrexate), heparin, etc. ? Disuse systemic osteoporosis can be seen in long-term bed rest, paraplegia, space flight, etc; Local bone atrophy can be seen after fracture, sudecks bone atrophy, post injury bone atrophy, etc. ? Gastrectomy for gastrointestinal malabsorption. ? Rheumatoid arthritis. ? Tumor, multiple myeloma, metastatic cancer, monocytic leukemia, mast cell disease, etc. ? Other causes include osteopenia, transient or migratory osteoporosis.
研究者
相似试验
尚未招募
1 期
Clinical study on Yanghe Decoction in improving neo-adjuvant chemotherapy efficacy and immune function of breast cancer patientsbreast cancerITMCTR2000003712Yueyang Hospital of Integrated Chinese and Western Medicine, Shanghai University of TCM
招募中
1 期
Clinical study of jiuwei Yongan Decoction in treating atopic dermatitis (blood deficiency, wind dryness syndrome)Atopic dermatitisITMCTR2000004007Shanghai Changhai Hospital
招募中
1 期
Clinical study on Yixiao Decoction in the treatment of type 2 diabetes complicated with left ventricular diastolic dysfunctioType 2 DiabetesITMCTR2100004708Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
尚未招募
3 期
Clinical Study of ''Jieyu Xingyang decoction'' in treating erectile dysfunction caused by antipsychoticErectile dysfunction due to antipsychoticsITMCTR2200005913Affiliated Brain Hospital of Guangzhou Medical University
尚未招募
不适用
Clinical study for 'Yi-Qin-Fang' decoction in the treatment of uric acid nephropathy by high colon pathwayric acid nephropathyITMCTR1900002859Shenzhen Second People's Hospital
